China, Oct. 14 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Efficacy of neoadjuvant immunotherapy combined with chemotherapy versus chemotherapy alone in gastric cancer: a retrospective study and construction of a prognostic prediction model'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600134322
Registration Time: 2026/10/13
Type: Observational study
Primary Sponsor: Jiangsu Province Hospital (The First Affiliated Hospital with Nanjing Medical University)
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=341008
Published by HT Digital Content Services with permission from Health Daily Digest....